Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study

Abstract Background China incurs an extremely low treatment coverage of multidrug-resistant tuberculosis (MDR-TB). This study aimed to understand the experience of MDR-TB patients on quality of health care, and the clinical impact through an up to six-year follow-up. Methods Cohorts of MDR-TB patien...

Full description

Bibliographic Details
Main Authors: Xu-Bin Zheng, Vinod K. Diwan, Qi Zhao, Yi Hu, Judith Bruchfeld, Wei-Li Jiang, Sven Hoffner, Biao Xu
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Infectious Diseases of Poverty
Subjects:
Multidrug-resistant
Tuberculosis
Delay
Treatment
Follow-up
China
Online Access:http://link.springer.com/article/10.1186/s40249-020-00719-x

Internet

http://link.springer.com/article/10.1186/s40249-020-00719-x

Similar Items